查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1723657

医疗保健的非替代性权标(NFT)市场:使用区块链，各应用领域，各最终用途，各地区:2035年前的产业趋势与全球预测

Non-fungible Tokens (NFT) in Healthcare Market by Blockchain Used, Application Area, End-user and Geographical Regions: Industry Trends and Global Forecasts, till 2035
出版日期: | 出版商: Roots Analysis | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

医疗保健市场中的非同质化代币 (NFT)

全球医疗保健 NFT 市场规模预计在 2021 年达到 1.54 亿美元，2025 年达到 2.081 亿美元，2035 年达到 11,168 亿美元，预测期内复合年增长率为 18.3%。

医疗保健市场的 NFT 机会分布在以下领域：

所使用的区块链

  • 以太坊
  • 超级休閒
  • 多边形
  • 其他

应用领域

  • 医疗记录管理
  • 供应链管理
  • 基因研究
  • 健康与保健
  • 临床试验同意书
  • 其他

终端用户

  • 医疗保健相关人员
  • 患者
  • 製药公司
  • 学术机构/政府机关
  • 保险公司
  • 其他

地区

  • 北美(美国，加拿大)
  • 欧洲(德国，英国，西班牙，其他)
  • 亚太地区(中国，韩国，印度，其他)
  • 中东·北非(沙乌地阿拉伯，UAE，其他)
  • 南美(巴西，阿根廷，其他)

医疗保健领域的 NFT 市场：成长与趋势

NFT 市场是一个快速发展的领域，它透过整合去中心化的区块链技术，正在改变多个产业。区块链技术的采用促使各行各业从中心化系统转向去中心化网络，这带来了许多好处，包括提高交易速度、降低成本和增强资料完整性。值得注意的是，由于 NFT 储存并代币化在区块链上，因此具有许多优势（如上所述）。这些优势促进了近​​年来 NFT 的普及。事实上，2021 年，NFT 市场从 NFT 交易中获得了超过 400 亿美元的收入。这主要归功于艺术品行业的关键事件（数位艺术家 Beeple 售出了价值 6900 万美元的作品），这带来了 NFT 发展历史上的重大突破。

NFT 是艺术品、医疗数据和影片片段等资产的数位化表示，这些资产透过区块链技术进行代币化。 NFT 不可分割、不可篡改，且由于代币化资讯无法被第三方访问，因此具有高度的安全性和隐私性。由于上述特性，NFT 被广泛应用于艺术、供应链、时尚、游戏、医疗保健和房地产等各个领域。此外，NFT 还吸引了加密货币和区块链市场投资者和利害关係人的浓厚兴趣，从而推动了其应用范围的扩大。

在医疗保健领域，NFT 有多种用途，包括供应链追踪、健康记录管理​​、基因组研究、捐血、临床试验知情同意、医疗保健和健康计划。具体来说，医疗记录 NFT 在医疗保健行业中应用最为广泛，它使患者能够管理自身健康数据并与製药公司和研究机构进行交易。此外，为了充分发挥 NFT 在医疗保健领域的潜力，许多提供 NFT 解决方案的公司也在开发创新平台，以实现安全透明的资料储存和共享。

随着区块链及相关先进技术的认知度和应用度不断提升，医疗保健产业对 NFT 解决方案的需求正在稳步增长。此外，由于名人对数位资产的认可以及医疗数据处理的迫切需求，预计未来几年医疗保健领域的 NFT 市场将稳步增长。

医疗保健领域的 NFT 市场：关键洞察

本报告探讨了医疗保健领域 NFT 市场的现状，并识别了潜在的成长机会。主要发现包括：

  • 受各种医疗保健应用对安全性和可靠性需求的推动，已有 30 多种 NFT 解决方案被推出/开发。
Non-fungible Tokens(NFT)in Healthcare Market-IMG1
  • 目前，市场上有超过 65% 的 NFT 平台，其中 30% 具备资料共享、智慧合约、去中心化、代币化、不可篡改性和安全性等所有关键特性。
Non-fungible Tokens(NFT)in Healthcare Market-IMG2
  • 该领域约 45% 的交易专注于增强 NFT 解决方案，以改善医疗保健数据管理和可访问性，其中大多数跨洲交易由北美参与者达成。
  • 在过去几年中，医疗保健领域的 NFT 解决方案提供者透过多轮融资筹集了超过 9,000 万美元。
  • 加密货币的广泛采用和患者货币化机会的增加正在推动医疗保健领域非同质化代币市场的发展，预计该市场在短期内将实现稳定增长。
Non-fungible Tokens(NFT)in Healthcare Market-IMG3
  • 鑑于人们日益认识到去中心化等原则，加上 NFT 提供的无与伦比的资料安全性，预计到 2035 年，该市场的复合年增长率 (CAGR) 将达到 18.3%。

医疗保健领域的 NFT 市场：关键细分市场

根据所使用的区块链，全球医疗保健领域的 NFT 市场细分为以太坊、Hyperledger、Polygon 和其他区块链。目前，利用以太坊区块链网路的 NFT 解决方案已占据医疗保健领域 NFT 市场的大部分占有率。这是因为以太坊区块链提供了增强的安全性和隐私性（因为它是第一个实现智慧合约的区块链），并且不需要第三方验证。值得一提的是，利用其他区块链的 NFT 解决方案在未来几年可能会大幅成长。

按应用领域划分，全球医疗保健领域的 NFT 市场分布在医疗记录管理、供应链管理、基因组研究、健康与保健、临床试验知情同意和其他应用领域。由于 NFT 能够有效追踪电子病历并支持精准诊断和治疗，因此医疗记录管理领域目前很可能占据整个市场的主导地位。值得注意的是，这一趋势在预测期内不太可能改变。

按终端用户划分，全球 NFT 市场细分为医疗保健专业人员、患者、製药公司、学术/政府机构、保险公司和其他终端用户。值得注意的是，目前市场主要由医疗保健专业人员使用的 NFT 解决方案主导。然而，在未来几年，满足患者需求的NFT解决方案预计将显着成长。

依地区划分，市场细分为北美、欧洲、亚太地区、中东和北非、拉丁美洲。目前，北美很可能在医疗保健市场的NFT中占据主导地位。然而，由于研发活动的增加、认知度的提升以及NFT解决方案的采用率的提高，预计亚太地区医疗保健市场的NFT在预测期内将以更高的复合年增长率成长。

报告中解答的关键问题

  • 目前有多少家公司参与该市场？
  • 该市场的主要公司
  • 可能影响该市场发展的因素
  • 当前与未来的市场规模
  • 该市场的复合年增长率
  • 当前和未来的市场机会可能如何在主要细分市场中分配？
  • 产业利害关係人常用的合作模式类型
  • 该市场的持续投资趋势

为何购买此报告？

  • 本报告提供全面的市场分析，并针对整体市场和特定细分市场提供详细的收入预测。这些资讯对于现有的市场领导者和新进入者都极具价值。
  • 利害关係人可以利用本报告深入了解市场中的竞争动态。透过分析竞争格局，企业可以做出明智的决策，优化市场定位并制定有效的市场进入策略。
  • 本报告为利害关係人提供了全面的市场概览，包括关键推动因素、阻碍因素和课题。这些资讯使利害关係人能够掌握市场趋势，并做出基于数据的决策，从而掌握成长前景。

更多优势

  • PPT 洞察包
  • 报告所有分析模组可免费取得 Excel 资料包
  • 10% 免费内容客製化
  • 由我们的研究团队提供详细的报告讲解
  • 如果报告超过 6-12 个月，可免费更新报告

本报告提供全球医疗保健的非替代性权标(NFT)市场相关调查，提供市场概要，以及使用区块链，各应用领域，各最终用途，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

章节I:报告概要

第1章 背景

第2章 调查手法

第3章 市场动态

第4章 宏观经济指标

章节II:定性性的洞察

第5章 摘要整理

第6章 简介

  • 非替代性权标(NFT)概要
  • 区块链流程
  • NFT的主要特征
  • NFT的使用案例
  • 医疗保健的NFT的应用
  • 医疗保健领域的NFT的课题
  • 未来展望

章节III:市场概要

第7章 竞争情形

  • 调查手法主要的参数
  • 医疗保健的NFT解决方案:市场形势
  • 医疗保健的NFT解决方案供应商:市场形势

第8章 企业竞争力分析

  • 研究方法与关键参数
  • 评分标准
  • 同侪评审
  • 医疗保健领域的 NFT 解决方案提供者：公司竞争力分析
  • 医疗保健领域的 NFT 解决方案提供者：基准分析

章节IV:企业简介

第9章 企业简介

章节V:市场趋势

第10章 伙伴关係和合作

  • 伙伴关係模式
  • 医疗保健的非替代性权标:伙伴关係和合作

第11章 资金筹措与投资

  • 资金筹措模式
  • 医疗保健的非替代性权标:资金筹措与投资
  • 摘要重要的要点

第12章 医疗保健的非替代性权标:使用案例

  • NFT使用案例概要
  • NFT的潜在的使用案例

章节VI:市场预测与机会分析

第13章 市场影响分析:促进因素，阻碍因素，机会，课题

  • 章概要
  • 市场促进因素
  • 市场阻碍因素
  • 市场机会
  • 市场课题
  • 结论

第14章：全球医疗保健市场中的非同质化代币

  • 关键假设与研究方法
  • 全球医疗保健市场中的非同质化代币，历史趋势（2021年起）及预测（至2035年）
  • 主要的市场区隔

第15章 医疗保健市场上非替代权标市场(使用区块链)

第16章 医疗保健的非替代性权标市场(各应用领域)

第17章 医疗保健的非替代性权标市场(各终端用户)

第18章 医疗保健的非替代性权标市场(各地区)

章节VII:地理地区的市场机会分析

第19章 市场机会分析:北美

第20章 市场机会分析:欧洲

第21章 市场机会分析:亚太地区

第22章 市场机会分析:中东与北非

第23章 市场机会分析:南美

章节VIII:策略工具

第24章 波特的五力分析

章节IX:其他的垄断的洞察

第25章 结论

第26章 来自1次调查的洞察

章节X:附录

第27章 表格形式资料

第28章 企业·团体一览

Product Code: RA100522

NON-FUNGIBLE TOKENS (NFT) IN HEALTHCARE MARKET

As per Roots Analysis, the global NFT in healthcare market, valued at USD 154.0 million in 2021, is projected to reach USD 208.1 million in 2025 and USD 1,116.8 billion by 2035, representing a CAGR of 18.3% during the forecast period.

The opportunity for NFT in the healthcare market has been distributed across the following segments:

Blockchain Used

  • Ethereum
  • HyperLedger
  • Polygon
  • Other Blockchains

Application Area

  • Health Records Management
  • Supply Chain Management
  • Genomics Research
  • Health and Wellness
  • Clinical Trial Consent
  • Other Application Areas

End-user

  • Healthcare Professionals
  • Patients
  • Pharmaceutical Companies
  • Academic Institutions / Government Bodies
  • Insurance Companies
  • Other End-users

Geographical Regions

  • North America (US and Canada)
  • Europe (Germany, UK, Spain and Rest of the Europe)
  • Asia-Pacific (China, South Korea, India and Rest of the Asia-Pacific)
  • Middle East and North Africa (Saudi Arabia, UAE and Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina and Rest of the Latin America)

NFT IN HEALTHCARE MARKET: GROWTH AND TRENDS

The NFT market is a rapidly evolving sector that is transforming several industries by integrating decentralized blockchain technology. The incorporation of blockchain technology has prompted various industries to shift from centralized systems to decentralized networks, offering several advantages, such as enhanced transaction speeds, reduced costs, and improved data integrity. It is worth highlighting that NFTs are stored and tokenized on blockchain and therefore offer several advantages (mentioned above). These advantages have further contributed to the increased adoption of NFTs in recent years. In fact, in 2021, the NFT market generated more than USD 40 billion in revenues by trading NFTs; primarily attributed to an important event in the artwork industry (wherein Beeple, a digital artist, sold a piece of his artwork worth USD 69 million) that marked a significant breakthrough in the history of NFTs.

NFTs are distinct digital representations of assets, such as artwork, medical data, and video clips that have been tokenized through blockchain technology. It is worth noting that NFTs are non-divisible, immutable, and provide high security and privacy, since third parties cannot access the tokenized information. Owing to the abovementioned features, NFTs are being used across multiple disciplines, such as art, supply chain, fashion, gaming, healthcare, and real estate. Further, NFTs have gained significant interest from investors and stakeholders engaged in the cryptocurrency and blockchain market, contributing to their increased adoption.

In healthcare, NFTs are being used for several applications, including tracking supply chain, managing health records, genomics research, blood donation, clinical trial consent, healthcare and wellness programs. Notably, the NFTs for medical records are most commonly used in the healthcare industry, which allows patients to control their health-related data and trade it with pharmaceutical firms and research institutions. Moreover, to fully realize the potential of NFTs in the healthcare sector, various companies providing NFT solutions are also developing innovative platforms that enable secure and transparent storage and sharing of data.

Given the rising awareness and increased adoption of blockchain and related advanced technologies, the demand for NFT solutions in the healthcare industry is increasing at a steady pace. Moreover, the celebrity endorsements of digital assets and the urgent need to handle healthcare data, the NFT in healthcare market is expected to witness steady growth in the forthcoming years.

NFT IN HEALTHCARE MARKET: KEY INSIGHTS

The report delves into the current state of the NFT in healthcare market and identifies potential growth opportunities within the industry. Some key findings from the report include:

  • Driven by the need for security and reliability across various healthcare applications, over 30 NFT solutions have been launched / under development; notably, the market landscape primarily features the presence of new entrants.
Non-fungible Tokens (NFT) in Healthcare Market - IMG1
  • Presently, more than 65% of the NFT platforms are available in the market; of these, 30% of the platforms have all the key features, namely data sharing, smart contracts, decentralization, tokenization, immutability and security.
Non-fungible Tokens (NFT) in Healthcare Market - IMG2
  • Around 45% of the deals inked in this domain were focused on enhancing NFT solutions to improve health data management and accessibility; the majority of the intercontinental deals were signed by players based in North America.
  • Over the past few years, more than USD 90 million has been raised across various funding rounds by NFT solution providers in healthcare; of which, 80% of the total amount was raised by players based in Europe.
  • The rise in adoption of cryptocurrencies coupled with monetization opportunities for patients drives the non-fungible tokens in healthcare market, positioning it for steady growth in the foreseeable future.
Non-fungible Tokens (NFT) in Healthcare Market - IMG3
  • Given the rising awareness regarding principles such as decentralization coupled with unmatched data security offered by NFTs, the market is anticipated to grow at an annualized rate (CAGR) of 18.3% till 2035.

NFT IN HEALTHCARE MARKET: KEY SEGMENTS

NFT Solutions Utilizing Ethereum Blockchain Network is Likely to Dominate the NFT in Healthcare Market During the Forecast Period

Based on the blockchain used, the global NFT in healthcare market is segmented into Ethereum, HyperLedger, Polygon and other blockchains. Currently, the majority share of the NFT in healthcare market is captured by NFT solutions utilizing Ethereum blockchain network. This can be attributed to the fact that Ethereum blockchain offers enhanced security and privacy (as this was the first blockchain to implement smart contracts) and does not require third-party verification. It is worth mentioning that the NFT solutions utilizing other blockchains are likely to grow at a significant pace in the coming years.

Health Records Management Segment is Likely to Hold the Largest Share of the NFT in Healthcare Market During the Forecast Period

Based on the application area, the global NFT in healthcare market is distributed across health records management, supply chain management, genomics research, health and wellness, clinical trial consent and other application areas. Currently, the health records management segment is likely to dominate the overall market, as NFTs enable the tracking of electronic health records effectively, which supports accurate diagnosis and treatment. Notably, this trend is unlikely to change during the forecast period.

Currently, NFT Solutions Catering to Healthcare Professionals Hold the Largest Share of the NFT in Healthcare Market

Based on the end-user, the global NFT in healthcare market is segmented into healthcare professionals, patients, pharmaceutical companies, academic institutions / government bodies, insurance companies and other end-users. It is worth noting that the current market is likely to be dominated by NFT solutions being utilized by healthcare professionals. However, in the coming years, the NFT solutions catering to patient needs are expected to witness substantial growth.

North America Accounts for the Largest Share of the Market

Based on geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. In the current scenario, North America is likely to dominate the NFT in healthcare market. However, owing to the increasing research and development activity, rising awareness and increased adoption of NFT solutions, the NFT in healthcare market in Asia-Pacific is expected to grow at a higher CAGR during the forecast period.

Example Players in the NFT in Healthcare Market

  • Aimedis
  • BurstIQ
  • ChainCode Consulting
  • DeHealth
  • Epillo Health
  • GenoBank.io
  • Genomes.io
  • IVIRSE
  • Molecule
  • Rejuve.AI
  • TuumIO
  • Universal Health Token

NFT IN HEALTHCARE MARKET: RESEARCH COVERAGE

The report on NFT in healthcare market features insights into various sections, including:

  • Market Sizing and Opportunity Analysis: An in-depth analysis of NFT in healthcare market, focusing on key market segments, including [A] blockchain used, [B] application area, [C] end-user, and [D] geographical regions.
  • Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
  • NFT Solutions Market Landscape: An insightful analysis of various NFT solutions based on several relevant parameters, such as [A] stage of development, [B] key features, [C] application area, and [D] end-user. Additionally, this section also features analyses of the companies engaged in this domain, based on [A] company size, [B] location of headquarters, and [C] year of establishment.
  • Company Competitiveness Analysis: An insightful competitiveness analysis of NFT solution providers based on various relevant parameters, such as [A] supplier strength, [B] portfolio strength, and [C] portfolio diversity.
  • Company Profiles: Elaborate profiles of leading players developing NFT solutions across various geographies, including North America, Europe, Asia-Pacific and rest of the world, providing details on [A] company overview, [B] NFT solution overview, [C] recent developments and [D] an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders engaged in NFT in healthcare industry, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] application area, [E] most active players and [F] geographical distribution of partnership activity.
  • Funding and Investment Analysis: An in-depth analysis of funding and investments made in the NFT in healthcare domain, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] geography, and [E] most active players.
  • Case Study: A detailed assessment of the existing and potential use cases of non-fungible tokens across several healthcare applications, highlighting their capacity to revolutionize health data management and enhancing patient care.
  • Porter's Five Forces Analysis: An analysis of five competitive forces prevailing in the NFT in healthcare industry, including threats of new entrants, bargaining power of buyers, bargaining power of NFT in healthcare solution providers, threats of substitute products and rivalry among existing competitors.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?
  • What types of partnership models are commonly adopted by industry stakeholders?
  • What is the ongoing investment trend in this market?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 10% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. BACKGROUND

  • 1.1. Context
  • 1.2. Project Objectives

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
    • 2.2.1. Market Landscape and Market Trends
    • 2.2.2. Market Forecast and Opportunity Analysis
    • 2.2.3. Comparative Analysis
  • 2.3. Database Building
    • 2.3.1. Data Collection
    • 2.3.2. Data Validation
    • 2.3.3. Data Analysis
  • 2.4. Project Methodology
    • 2.4.1. Secondary Research
      • 2.4.1.1. Annual Reports
      • 2.4.1.2. Academic Research Papers
      • 2.4.1.3. Company Websites
      • 2.4.1.4. Investor Presentations
      • 2.4.1.5. Regulatory Filings
      • 2.4.1.6. White Papers
      • 2.4.1.7. Industry Publications
      • 2.4.1.8. Conferences and Seminars
      • 2.4.1.9. Government Portals
      • 2.4.1.10. Media and Press Releases
      • 2.4.1.11. Newsletters
      • 2.4.1.12. Industry Databases
      • 2.4.1.13. Roots Proprietary Databases
      • 2.4.1.14. Paid Databases and Sources
      • 2.4.1.15. Social Media Portals
      • 2.4.1.16. Other Secondary Sources
    • 2.4.2. Primary Research
      • 2.4.2.1. Types of Primary Research
        • 2.4.2.1.1. Qualitative Research
        • 2.4.2.1.2. Quantitative Research
        • 2.4.2.1.3. Hybrid Approach
      • 2.4.2.2. Advantages of Primary Research
      • 2.4.2.3. Techniques for Primary Research
        • 2.4.2.3.1. Interviews
        • 2.4.2.3.2. Surveys
        • 2.4.2.3.3. Focus Groups
        • 2.4.2.3.4. Observational Research
        • 2.4.2.3.5. Social Media Interactions
      • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
        • 2.4.2.4.1. Company Executives (CXOs)
        • 2.4.2.4.2. Board of Directors
        • 2.4.2.4.3. Company Presidents and Vice Presidents
        • 2.4.2.4.4. Research and Development Heads
        • 2.4.2.4.5. Technical Experts
        • 2.4.2.4.6. Subject Matter Experts
        • 2.4.2.4.7. Scientists
        • 2.4.2.4.8. Doctors and Other Healthcare Providers
      • 2.4.2.5. Ethics and Integrity
        • 2.4.2.5.1. Research Ethics
        • 2.4.2.5.2. Data Integrity
    • 2.4.3. Analytical Tools and Databases
  • 2.5. Robust Quality Control

3. MARKET DYNAMICS

  • 3.1. Chapter Overview
  • 3.2. Forecast Methodology
    • 3.2.1. Top-down Approach
    • 3.2.2. Bottom-up Approach
    • 3.2.3. Hybrid Approach
  • 3.3. Market Assessment Framework
    • 3.3.1. Total Addressable Market (TAM)
    • 3.3.2. Serviceable Addressable Market (SAM)
    • 3.3.3. Serviceable Obtainable Market (SOM)
    • 3.3.4. Currently Acquired Market (CAM)
  • 3.4. Forecasting Tools and Techniques
    • 3.4.1. Qualitative Forecasting
    • 3.4.2. Correlation
    • 3.4.3. Regression
    • 3.4.4. Extrapolation
    • 3.4.5. Convergence
    • 3.4.6. Sensitivity Analysis
    • 3.4.7. Scenario Planning
    • 3.4.8. Data Visualization
    • 3.4.9. Time Series Analysis
    • 3.4.10. Forecast Error Analysis
  • 3.5. Key Considerations
    • 3.5.1. Demographics
    • 3.5.2. Government Regulations
    • 3.5.3. Reimbursement Scenarios
    • 3.5.4. Market Access
    • 3.5.5. Supply Chain
    • 3.5.6. Industry Consolidation
    • 3.5.7. Pandemic / Unforeseen Disruptions Impact
  • 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

  • 4.1. Chapter Overview
  • 4.2. Market Dynamics
    • 4.2.1. Time Period
      • 4.2.1.1. Historical Trends
      • 4.2.1.2. Current and Forecasted Estimates
    • 4.2.2. Currency Coverage
      • 4.2.2.1. Major Currencies Affecting the Market
      • 4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
      • 4.2.2.3. Impact of Currency Fluctuations on the Industry
    • 4.2.3. Foreign Currency Exchange Rate
      • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
      • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 4.2.4. Recession
      • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
      • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.2.5. Inflation
      • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
    • 4.2.6. Interest Rates
      • 4.2.6.1. Interest Rates and Their Impact on the Market
      • 4.2.6.2. Strategies for Managing Interest Rate Risk
    • 4.2.7. Commodity Flow Analysis
      • 4.2.7.1. Type of Commodity
      • 4.2.7.2. Origins and Destinations
      • 4.2.7.3. Values and Weights
      • 4.2.7.4. Modes of Transportation
    • 4.2.8. Global Trade Dynamics
      • 4.2.8.1. Import Scenario
      • 4.2.8.2. Export Scenario
      • 4.2.8.3. Trade Policies
      • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
      • 4.2.8.5. Impact of Trade Barriers on the Market
    • 4.2.9. War Impact Analysis
      • 4.2.9.1. Russian-Ukraine War
      • 4.2.9.2. Israel-Hamas War
    • 4.2.10. COVID Impact / Related Factors
      • 4.2.10.1. Global Economic Impact
      • 4.2.10.2. Industry-specific Impact
      • 4.2.10.3. Government Response and Stimulus Measures
      • 4.2.10.4. Future Outlook and Adaptation Strategies
    • 4.2.11. Other Indicators
      • 4.2.11.1. Fiscal Policy
      • 4.2.11.2. Consumer Spending
      • 4.2.11.3. Gross Domestic Product
      • 4.2.11.4. Employment
      • 4.2.11.5. Taxes
      • 4.2.11.6. Stock Market Performance
      • 4.2.11.7. Cross Border Dynamics
  • 4.3. Conclusion

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION

  • 6.1. Overview of Non-fungible Tokens (NFTs)
  • 6.2. Blockchain Process
  • 6.3. Key Features of NFTs
  • 6.4. NFTs Use Cases
  • 6.5. Applications of NFTs in Healthcare
  • 6.6. Challenges Associated with NFTs in Healthcare Domain
  • 6.7. Future Perspectives

SECTION III: MARKET OVERVIEW

7. COMPETITIVE LANDSCAPE

  • 7.1. Methodology and Key Parameters
  • 7.2. NFT Solutions in Healthcare: Overall Market Landscape
    • 7.2.1. Analysis by Stage of Development
    • 7.2.2. Analysis by Key Features of NFTs
    • 7.2.3. Analysis by Application Area
    • 7.2.4. Analysis by End-user
  • 7.3. NFT Solution Providers in Healthcare: Overall Market Landscape
    • 7.3.1. Analysis by Year of Establishment
    • 7.3.2. Analysis by Company Size
    • 7.3.3. Analysis by Location of Headquarters

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Methodology and Key Parameters
  • 8.2. Scoring Criteria
  • 8.3. Peer Groups
    • 8.3.1. Overview of Peer Groups
  • 8.4. NFT in Healthcare Solution Providers: Company Competitiveness Analysis
    • 8.4.1. NFT Solution Providers in North America: Peer Group I
      • 8.4.1.1. Leading Players in Peer Group I
    • 8.4.2. NFT Solution Providers in Europe: Peer Group II
      • 8.4.2.1. Leading Players in Peer Group II
    • 8.4.3. NFT Solution Providers in Asia-Pacific and Rest of the World: Peer Group III
      • 8.4.3.1. Leading Players in Peer Group III
  • 8.5. NFT in Healthcare Solution Providers: Benchmarking Analysis
    • 8.5.1. Benchmarking of Supplier Strength Score
    • 8.5.2. Benchmarking of Portfolio Strength Score
    • 8.5.3. Benchmarking of Portfolio Diversity Score

SECTION IV: COMPANY PROFILES

9. COMPANY PROFILES

  • 9.1. Overview
  • 9.2. Leading Non-fungible Token Solution Providers in Healthcare
    • 9.2.1. Aimedis
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Company Mission
      • 9.2.1.3. Management Team
      • 9.2.1.4. Contact Details
      • 9.2.1.5. NFT Solution Overview
      • 9.2.1.6. Recent Initiatives
    • 9.2.2. BurstIQ
    • 9.2.3. DeHealth
    • 9.2.4. GenoBank.io
    • 9.2.5. Tuumio
  • 9.3. Other Prominent Non-fungible Token Solution Providers in Healthcare
    • 9.3.1. ChainCode Consulting
      • 9.3.1.1. Company Mission
      • 9.3.1.2. Management Team
      • 9.3.1.3. NFT Solution Overview
      • 9.3.1.4. Recent Initiatives
    • 9.3.2. Epillo Health
    • 9.3.3. Genomes.io
    • 9.3.4. IVIRSE
    • 9.3.5. Molecule
    • 9.3.6. Rejuve.AI
    • 9.3.7. Universal Health Token

SECTION V: MARKET TRENDS

10. PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Partnership Models
  • 10.2. Non-fungible Tokens in Healthcare: Partnerships and Collaborations
    • 10.2.1. Analysis by Year of Partnership
    • 10.2.2. Analysis by Type of Partnership
    • 10.2.3. Analysis by Year and Type of Partnership
    • 10.2.4. Analysis by Type of Partner
    • 10.2.5. Analysis by Application Area
    • 10.2.6. Analysis by Geographical Activity
    • 10.2.7. Most Active Players: Analysis by Number of Partnerships

11. FUNDING AND INVESTMENTS

  • 11.1. Funding Models
  • 11.2. Non-fungible Tokens in Healthcare: Funding and Investments
    • 11.2.1. Analysis by Year of Funding
    • 11.2.2. Analysis of Funding Instances by Type of Funding
    • 11.2.3. Analysis of Funding Instances by Year and Type of Funding
    • 11.2.4. Analysis of Amount Invested by Type of Funding
    • 11.2.5. Analysis of Funding Instances by Country
    • 11.2.6. Most Active Players: Analysis by Amount Raised
  • 11.3. Summary and Key Takeaways

12. NON-FUNGIBLE TOKENS IN HEALTHCARE: USE CASES

  • 12.1. Overview of NFT Use Cases
    • 12.1.1. Use Case 1: Auctioning Genomic Data
    • 12.1.2. Use Case 2: DNA Kits
    • 12.1.3. Use Case 3: Blood Donation
    • 12.1.4. Use Case 4: Stem Cell Research
    • 12.1.5. Use Case 5: Digital Health Clinics
    • 12.1.6. Use Case 6: Charitable Health NFTs
    • 12.1.7. Use Case 7: Marketing NFTs
    • 12.1.8. Use Case 8: Supply Chain Traceability
  • 12.2. Potential NFT Use Cases

SECTION VI: MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 13.1. Chapter Overview
  • 13.2. Market Drivers
  • 13.3. Market Restraints
  • 13.4. Market Opportunities
  • 13.5. Market Challenges
  • 13.6. Conclusion

14. GLOBAL Non-fungible TOKENS in healthcare MARKET

  • 14.1. Key Assumptions and Methodology
  • 14.2. Global Non-fungible Tokens in Healthcare Market, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 14.2.1. Multivariate Scenario Analysis
      • 14.2.1.1. Conservative Scenario
      • 14.2.1.2. Optimistic Scenario
  • 14.3. Key Market Segmentations

15. Non-fungible TOKENS in healthcare MARKET, BY Blockchain Used

  • 15.1. Key Assumptions and Methodology
  • 15.2. Non-fungible Tokens in Healthcare Market: Distribution by Blockchain Used
    • 15.2.1. Non-fungible Tokens in Healthcare Market for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 15.2.2. Non-fungible Tokens in Healthcare Market for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 15.2.3. Non-fungible Tokens in Healthcare Market for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 15.2.4. Non-fungible Tokens in Healthcare Market for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.3. Data Triangulation and Validation
    • 15.3.1. Secondary Sources
    • 15.3.2. Primary Sources

16. Non-fungible TOKENS in Healthcare MARKET, BY APPLICATION AREA

  • 16.1. Key Assumptions and Methodology
  • 16.2. Non-fungible Tokens in Healthcare Market: Distribution by Application Area
    • 16.2.1. Non-fungible Tokens in Healthcare Market for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 16.2.2. Non-fungible Tokens in Healthcare Market for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 16.2.3. Non-fungible Tokens in Healthcare Market for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 16.2.4. Non-fungible Tokens in Healthcare Market for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 16.2.5. Non-fungible Tokens in Healthcare Market for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 16.2.6. Non-fungible Tokens in Healthcare Market for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.3. Data Triangulation and Validation
    • 16.3.1. Secondary Sources
    • 16.3.2. Primary Sources

17. Non-fungible TOKENS in healthcare MARKET, BY End-user

  • 17.1. Key Assumptions and Methodology
  • 17.2. Non-fungible Tokens in Healthcare Market: Distribution by End-user
    • 17.2.1. Non-fungible Tokens in Healthcare Market for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 17.2.2. Non-fungible Tokens in Healthcare Market for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 17.2.3. Non-fungible Tokens in Healthcare Market for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 17.2.4. Non-fungible Tokens in Healthcare Market for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 17.2.5. Non-fungible Tokens in Healthcare Market for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 17.2.6. Non-fungible Tokens in Healthcare Market for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.3. Data Triangulation and Validation
    • 17.3.1. Secondary Sources
    • 17.3.2. Primary Sources

18. Non-fungible TOKENS in healthcare MARKET, BY Geographical Regions

  • 18.1. Key Assumptions and Methodology
  • 18.2. Non-fungible Tokens in Healthcare Market: Distribution by Geographical Regions
    • 18.2.1. Non-fungible Tokens in Healthcare Market in North America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.1.1. Non-fungible Tokens in Healthcare Market in the US, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.1.2. Non-fungible Tokens in Healthcare Market in Canada, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2. Non-fungible Tokens in Healthcare Market in Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.2.1. Non-fungible Tokens in Healthcare Market in Germany, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.2.2. Non-fungible Tokens in Healthcare Market in the UK, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.2.3. Non-fungible Tokens in Healthcare Market in Spain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.2.4. Non-fungible Tokens in Healthcare Market in Rest of the Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.3.1. Non-fungible Tokens in Healthcare Market in China, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.3.2. Non-fungible Tokens in Healthcare Market in the South Korea, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.3.3. Non-fungible Tokens in Healthcare Market in India, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.3.4. Non-fungible Tokens in Healthcare Market in Rest of the Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.4.1. Non-fungible Tokens in Healthcare Market in Saudi Arabia, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.4.2. Non-fungible Tokens in Healthcare Market in UAE, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.4.3. Non-fungible Tokens in Healthcare Market in Rest of the Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5. Non-fungible Tokens in Healthcare Market in Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.5.1. Non-fungible Tokens in Healthcare Market in Brazil, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.5.2. Non-fungible Tokens in Healthcare Market in Argentina, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
      • 18.2.5.3. Non-fungible Tokens in Healthcare Market in Rest of the Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.3 Non-fungible Tokens in Healthcare Market, By Geographical Regions: Market Dynamics Assessment
    • 18.3.1. Penetration-Growth (P-G) Matrix
    • 18.3.2. Market Movement Analysis
  • 18.4. Data Triangulation and Validation
    • 18.4.1. Secondary Sources
    • 18.4.2. Primary Sources

SECTION VII: MARKET OPPORTUNITY ANALYSIS WITHIN GEOGRAPHICAL REGIONS**

19. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

  • 19.1. Non-fungible Tokens in Healthcare Market in North America: Distribution by Blockchain Used
    • 19.1.1. Non-fungible Tokens in Healthcare Market in North America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.1.2. Non-fungible Tokens in Healthcare Market in North America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.1.3. Non-fungible Tokens in Healthcare Market in North America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.1.4. Non-fungible Tokens in Healthcare Market in North America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2. Non-fungible Tokens in Healthcare Market in North America: Distribution by Application Area
    • 19.2.1. Non-fungible Tokens in Healthcare Market in North America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.2.2. Non-fungible Tokens in Healthcare Market in North America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.2.3. Non-fungible Tokens in Healthcare Market in North America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.2.4. Non-fungible Tokens in Healthcare Market in North America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.2.5. Non-fungible Tokens in Healthcare Market in North America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.2.6. Non-fungible Tokens in Healthcare Market in North America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3. Non-fungible Tokens in Healthcare Market in North America: Distribution by End-user
    • 19.3.1. Non-fungible Tokens in Healthcare Market in North America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.3.2. Non-fungible Tokens in Healthcare Market in North America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.3.3. Non-fungible Tokens in Healthcare Market in North America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.3.4. Non-fungible Tokens in Healthcare Market in North America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.3.5. Non-fungible Tokens in Healthcare Market in North America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 19.3.6. Non-fungible Tokens in Healthcare Market in North America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

20. MARKET OPPORTUNITY ANALYSIS: EUROPE

  • 20.1. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Blockchain Used
    • 20.1.1. Non-fungible Tokens in Healthcare Market in Europe for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.1.2. Non-fungible Tokens in Healthcare Market in Europe for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.1.3. Non-fungible Tokens in Healthcare Market in Europe for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.1.4. Non-fungible Tokens in Healthcare Market in Europe for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Application Area
    • 20.2.1. Non-fungible Tokens in Healthcare Market in Europe for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.2.2. Non-fungible Tokens in Healthcare Market in Europe for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.2.3. Non-fungible Tokens in Healthcare Market in Europe for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.2.4. Non-fungible Tokens in Healthcare Market in Europe for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.2.5. Non-fungible Tokens in Healthcare Market in Europe for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.2.6. Non-fungible Tokens in Healthcare Market in Europe for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3. Non-fungible Tokens in Healthcare Market in Europe: Distribution by End-user
    • 20.3.1. Non-fungible Tokens in Healthcare Market in Europe for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.3.2. Non-fungible Tokens in Healthcare Market in Europe for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.3.3. Non-fungible Tokens in Healthcare Market in Europe for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.3.4. Non-fungible Tokens in Healthcare Market in Europe for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.3.5. Non-fungible Tokens in Healthcare Market in Europe for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 20.3.6. Non-fungible Tokens in Healthcare Market in Europe for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

21. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

  • 21.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Blockchain Used
    • 21.1.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.1.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.1.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.1.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Application Area
    • 21.2.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.2.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.2.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.2.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.2.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by End-user
    • 21.3.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.3.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.3.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.3.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.3.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 21.3.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

22. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND NORTH AFRICA

  • 22.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Blockchain Used
    • 22.1.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.1.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.1.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.1.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Application Area
    • 22.2.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.2.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.2.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.2.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.2.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by End-user
    • 22.3.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.3.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.3.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.3.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.3.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 22.3.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

23. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

  • 23.1. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Blockchain Used
    • 23.1.1. Non-fungible Tokens in Healthcare Market in Latin America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.1.2. Non-fungible Tokens in Healthcare Market in Latin America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.1.3. Non-fungible Tokens in Healthcare Market in Latin America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.1.4. Non-fungible Tokens in Healthcare Market in Latin America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Application Area
    • 23.2.1. Non-fungible Tokens in Healthcare Market in Latin America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.2.2. Non-fungible Tokens in Healthcare Market in Latin America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.2.3. Non-fungible Tokens in Healthcare Market in Latin America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.2.4. Non-fungible Tokens in Healthcare Market in Latin America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.2.5. Non-fungible Tokens in Healthcare Market in Latin America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.2.6. Non-fungible Tokens in Healthcare Market in Latin America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by End-user
    • 23.3.1. Non-fungible Tokens in Healthcare Market in Latin America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.3.2. Non-fungible Tokens in Healthcare Market in Latin America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.3.3. Non-fungible Tokens in Healthcare Market in Latin America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.3.4. Non-fungible Tokens in Healthcare Market in Latin America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.3.5. Non-fungible Tokens in Healthcare Market in Latin America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 23.3.6. Non-fungible Tokens in Healthcare Market in Latin America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • *Detailed information on Section VII is available in the Excel Data Packs shared along with the report**

SECTION VIII: STRATEGIC TOOLS

24. PORTER'S FIVE FORCES ANALYSIS

  • 24.1. Overview
  • 24.2. Significance of Porter's Five Forces Analysis
  • 24.3. Methodology
  • 24.4. Porter's Five Forces
    • 24.4.1. Threats of New Entrants
    • 24.4.2. Bargaining Power of Buyers
    • 24.4.3. Bargaining Power of NFT Solution Providers
    • 24.4.4. Threats of Substitute Products
    • 24.4.5. Rivalry Among Existing Competitors
  • 24.5. Concluding Remarks

SECTION IX: OTHER EXCLUSIVE INSIGHTS

25. CONCLUDING INSIGHTS

26. INSIGHTS FROM PRIMARY RESEARCH

SECTION X: APPENDICES

27. TABULATED DATA

28. LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 7.1 NFT Solutions in Healthcare: Information on Solution Provider, Stage of Development, Launch Year, Blockchain Used and Key Features
  • Table 7.2 NFT Solutions in Healthcare: Information on Application Area
  • Table 7.3 NFT Solutions in Healthcare: Information on End-user
  • Table 7.4 NFT Solution Providers in Healthcare: Information on Year of Establishment, Headquarter and Company Size
  • Table 10.1 Non-fungible Tokens in Healthcare: List of Partnerships and Collaborations, since 2020
  • Table 11.1 Non-fungible Tokens in Healthcare: List of Funding and Investments, since 2018
  • Table 19.1 Non-fungible Tokens in Healthcare Market in North America: Distribution by Blockchain Used, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 19.2 Non-fungible Tokens in Healthcare Market in North America: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 19.3 Non-fungible Tokens in Healthcare Market in North America: Distribution by End-user, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 20.1 Non-fungible Tokens in Healthcare Market in Europe: Distribution by Blockchain Used, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 20.2 Non-fungible Tokens in Healthcare Market in Europe: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 20.3 Non-fungible Tokens in Healthcare Market in Europe: Distribution by End-user, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 21.1 Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Blockchain Used, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 21.2 Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 21.3 Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by End-user, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 22.1 Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Blockchain Used, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 22.2 Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 22.3 Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by End-user, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 23.1 Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Blockchain Used, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 23.2 Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • Table 23.3 Non-fungible Tokens in Healthcare Market in Latin America: Distribution by End-user, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035) (USD Million)
  • *Detailed information on Tables 19.1-23.3 is available in the Excel Data Packs shared along with the report
  • Table 27.1 NFT Solutions in Healthcare: Distribution by Stage of Development
  • Table 27.2 NFT Solutions in Healthcare: Distribution by Key Features of NFTs
  • Table 27.3 NFT Solutions in Healthcare: Distribution by Application Area
  • Table 27.4 NFT Solutions in Healthcare: Distribution by End-user
  • Table 27.5 NFT Solution Providers: Distribution by Year of Establishment
  • Table 27.6 NFT Solution Providers: Distribution by Company Size
  • Table 27.7 NFT Solution Providers: Distribution by Location of Headquarters
  • Table 27.8 Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 27.9 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 27.10 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 27.11 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 27.12 Partnerships and Collaborations: Distribution by Application Area
  • Table 27.13 Partnerships and Collaborations: Distribution by Geographical Activity
  • Table 27.14 Most Active Players: Distribution by Number of Partnerships
  • Table 27.15 Funding and Investments: Cumulative Year-wise Trend of Fundings and Investments
  • Table 27.16 Funding and Investments: Distribution of Funding Instances by Type of Funding
  • Table 27.17 Funding and Investments: Year-wise Distribution of Funding Instances by Type of Funding
  • Table 27.18 Funding and Investments: Distribution of Amount Invested by Type of Funding
  • Table 27.19 Funding and Investments: Distribution of Funding Instances by Country
  • Table 27.20 Most Active Players: Distribution by Amount Raised (USD Million)
  • Table 27.21 Funding and Investments: Summary
  • Table 27.22 Global Non-fungible Tokens in Healthcare Market, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.23 Non-fungible Tokens in Healthcare Market: Distribution by Blockchain Used
  • Table 27.24 Non-fungible Tokens in Healthcare Market for Ethereum Blockchain, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.25 Non-fungible Tokens in Healthcare Market for Hyperledger Blockchain, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.26 Non-fungible Tokens in Healthcare Market for Polygon Blockchain, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.27 Non-fungible Tokens in Healthcare Market for Other Blockchains, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.28 Non-fungible Tokens in Healthcare Market: Distribution by Application Area
  • Table 27.29 Non-fungible Tokens in Healthcare Market for Health Records Management, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.30 Non-fungible Tokens in Healthcare Market for Supply Chain Management, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.31 Non-fungible Tokens in Healthcare Market for Genomics Research, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.32 Non-fungible Tokens in Healthcare Market for Health and Wellness, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.33 Non-fungible Tokens in Healthcare Market for Clinical Trial Consent, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.34 Non-fungible Tokens in Healthcare Market for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.35 Non-fungible Tokens in Healthcare Market: Distribution by End-user
  • Table 27.36 Non-fungible Tokens in Healthcare Market for Healthcare Professionals, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.37 Non-fungible Tokens in Healthcare Market for Patients, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.38 Non-fungible Tokens in Healthcare Market for Pharmaceutical Companies, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.39 Non-fungible Tokens in Healthcare Market for Academic Institutions / Government Bodies, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.40 Non-fungible Tokens in Healthcare Market for Insurance Companies, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.41 Non-fungible Tokens in Healthcare Market for Other End-users, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.42 Non-fungible Tokens in Healthcare Market: Distribution by Geographical Regions
  • Table 27.43 Non-fungible Tokens in Healthcare Market in North America, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.44 Non-fungible Tokens in Healthcare Market in the US, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.45 Non-fungible Tokens in Healthcare Market in Canada, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.46 Non-fungible Tokens in Healthcare Market in Europe, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.47 Non-fungible Tokens in Healthcare Market in Germany, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.48 Non-fungible Tokens in Healthcare Market in the UK, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.49 Non-fungible Tokens in Healthcare Market in Spain, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.50 Non-fungible Tokens in Healthcare Market in Rest of the Europe, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.51 Non-fungible Tokens in Healthcare Market in Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.52 Non-fungible Tokens in Healthcare Market in China, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.53 Non-fungible Tokens in Healthcare Market in South Korea, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.54 Non-fungible Tokens in Healthcare Market in India, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.55 Non-fungible Tokens in Healthcare Market in Rest of the Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.56 Non-fungible Tokens in Healthcare Market in Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.57 Non-fungible Tokens in Healthcare Market in Saudi Arabia, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.58 Non-fungible Tokens in Healthcare Market in UAE, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.59 Non-fungible Tokens in Healthcare Market in Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.60 Non-fungible Tokens in Healthcare Market in Latin America, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.61 Non-fungible Tokens in Healthcare Market in Brazil, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.62 Non-fungible Tokens in Healthcare Market in Argentina, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
  • Table 27.63 Non-fungible Tokens in Healthcare Market in Latin America, Historical Trends (since 2021) and Forecasted Estimated (till 2035): Conservative, Base and Optimistic Scenario (USD Million)